Kaya Ltd. moves to reshape its capital structure
TL;DR
Based on the explanatory statement for the preferential issue, what is the stated end-use of funds—specifically, what portion is allocated to debt reduction versus working capital or clinic expansion?
The provided filing for Kaya Limited's preferential issue does not disclose the specific end-use breakdown between debt reduction, working capital, or clinic expansion.
While the board outcome specifies an aggregate cash consideration of Rs 49.99 crores raised through the preferential issuance of 1,824,150 equity shares at Rs 274.10 per share to Axana Estates LLP and Plutus Investments India Private Limited [1], the document notes that further required details are enclosed in Annexure I, which is not present in the supplied context [1]. Consequently, the exact allocation of funds across these categories remains an unstated disclosure in the available documentation.
How does the proposed ESOP pool expansion compare to the company's current outstanding equity base, and what is the historical trend of share-based payment expenses as a percentage of Kaya's total employee benefit costs?
ESOP Pool Expansion and Equity Base Comparison
Kaya Limited's Nomination and Remuneration Committee (NRC) and Board approved an increase of 4,00,000 stock options to the existing employee stock option pool under the Kaya ESOP Plan - 2021 [3]. Simultaneously, the company announced plans to raise Rs 49.99 Crores via a preferential issue, with shareholder approval sought at an Extraordinary General Meeting (EGM) [4].
Regarding the comparison against the company's current outstanding equity base, the exact total number of outstanding equity shares is not explicitly detailed in the current financial filings, preventing a precise numerical dilution ratio calculation for the newly added 4,00,000 options.
Historical Trend of Share-Based Payment Expenses
Share-based payment expenses, accounted for under the fair value method, show a negligible contribution to total employee benefit costs based on historical disclosures:
- FY23: Share-based compensation cost was reported at Rs 117.47 lakhs (Rs 1.17 Crores) [5].
- FY24: Share-based compensation cost shifted to a negative adjustment / reversal of Rs (0.11) lakhs [5]. Against total employee benefit costs of Rs 170.92 Crores (consolidated) [6] and Rs 54.34 Crores (standalone) [7] in FY24, share-based payments accounted for effectively 0% of total employee costs.
- FY25 and FY26: Total employee benefit costs stood at Rs 15.95 Crores (consolidated) and Rs 60.76 Crores (standalone) in FY25, rising to Rs 70.06 Crores on both consolidated and standalone bases in FY26 [6], [7]. However, explicit share-based payment expense figures for FY25 and FY26 are not separately disclosed in the retrieved filings.
Sources
- [1]Kaya Limited Board Outcome: Preferential Issue of Equity Shares and ESOP Pool Expansion — 2026-08-10T05:21:27.500000, p.1
- [2]Kaya Limited Board Outcome: Preferential Issue of Equity Shares and ESOP Pool Expansion — 2026-08-10T05:21:27.500000, p.4
- [3]Kaya Limited NRC approves 75,000 stock options under ESOS ... — Scanx, 2026-08-10T00:00:00
- [4]Kaya Ltd to Raise ₹49.99 Crore Via Preferential Issue, Expands ... — Whalesbook, 2026-09-05T00:00:00
- [5][PDF] Kaya Limited - NSE — Nsearchives, 2024-07-15T00:00:00
- [6]TTM Employee Cost
- [7]TTM Employee Cost
Keep digging